Hybridized Zoonotic Schistosoma Infections Result in Hybridized Morbidity Profiles: A Clinical Morbidity Study amongst Co-Infected Human Populations of Senegal
Authors:
- Cheikh B. FallCFCheikh B. Fall
- Sébastien LambertSLSébastien Lambert
- Elsa LégerELElsa Léger
- Lucy YasenevLYLucy Yasenev
- Amadou Djirmay GarbaAGAmadou Djirmay Garba
- Samba D. DiopSDSamba D. Diop
- Anna BorlaseABAnna Borlase
- Stefano CatalanoSCStefano Catalano
- Babacar FayeBFBabacar Faye
- Martin WalkerMWMartin Walker
- Mariama SeneMSMariama Sene
- Joanne P. WebsterJWJoanne P. Webster
Open Access
- 20 August 2021
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 9 (8) , 1776
Abstract
Hybridization of infectious agents is a major emerging public and veterinary health concern at the interface of evolution, epidemiology, and control. Whilst evidence of the extent of hybridization amongst parasites is increasing, their impact on morbidity remains largely unknown. This may be predicted to be particularly pertinent where parasites of animals with contrasting pathogenicity viably hybridize with human parasites. Recent research has revealed that viable zoonotic hybrids between human urogenital Schistosoma haematobium with intestinal Schistosoma species of livestock, notably Schistosoma bovis, can be highly prevalent across Africa and beyond. Examining human populations in Senegal, we found increased hepatic but decreased urogenital morbidity, and reduced improvement following treatment with praziquantel, in those infected with zoonotic hybrids compared to non-hybrids. Our results have implications for effective monitoring and evaluation of control programmes, and demonstrate for the first time the potential impact of parasite hybridizations on host morbidity.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council (BB/L018985/1, BB/S013822/1)
- European and Developing Countries Clinical Trials Partnership (RIA2017NIM-1842)
This publication has 48 references indexed in Scilit:
- Introgressive Hybridization of Schistosoma haematobium Group Species in Senegal: Species Barrier Break Down between Ruminant and Human SchistosomesPLOS Neglected Tropical Diseases, 2013
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Bladder Morbidity and Hepatic Fibrosis in Mixed Schistosoma haematobium and S. mansoni Infections: A Population-Wide Study in Northern SenegalPLOS Neglected Tropical Diseases, 2012
- The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatmentBMC Infectious Diseases, 2010
- Global trends in emerging infectious diseasesNature, 2008
- Schistosoma haematobiumInfection and Morbidity Before and After Large‐Scale Administration of Praziquantel in Burkina FasoThe Journal of Infectious Diseases, 2007
- Speciation by hybridization in Heliconius butterfliesNature, 2006
- Natural hybridization and the evolution of domesticated, pest and disease organismsMolecular Ecology, 2004
- Interactions between Schistosoma haematobium and Schistosoma mansoni in humans in north CameroonTropical Medicine & International Health, 2003
- Morbidity induced by Schistosoma haematobium infections, as assessed by ultrasound before and after treatment with praziquantel, in a recently expanded focus (Senegal River basin)Pathogens and Global Health, 1998